Atlas Trials

Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata

Clinical trial NCT01840046 · TERMINATED

Trial details

NCT number
NCT01840046
Sponsor
Centre Hospitalier Universitaire de Nice
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Alopecia Areata
Start date
2012-11-01
Primary completion
2012-11-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.